查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1192995

止血市場：按產品、應用、最終用戶分類：全球機會分析和行業預測，2021-2031 年

Coagulation Testing Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格

全球止血測試市場規模預計將從 2021 年的 31.017 億美元以 11.5% 的複合年增長率增長，從 2022 年到 2031 年，到 2031 年將達到 87.773 億美元。。

醫療保健專業人員使用凝血測試來評估止血系統。 該測試主要使用凝血儀來監測和評估凝塊形成和血液凝固的速度。 這些測試檢測血液動脈中是否存在血塊，從而降低心髒病發作、血栓形成和栓塞的風險。

止血（凝血）是一個調節血流和凝塊形成的複雜過程，受多種□和蛋白質控制。

由於凝血檢測設備的技術不斷發展，市場正在擴大。 凝血檢測市場的主要增長原因是深靜脈血栓形成 (DVT) 和血友病等各種凝血障礙的患病率上升，以及世界人口老齡化。 一項關於全球凝血檢測市場增長的研究對該市場進行了全面評估。

全球止血市場受到負面影響，因為嚴格的政府法規以及與測試和治療相關的高風險和成本將其使用限制在經濟上可行的人群中。增加。

在自我檢測技術方面，基於智能手機的凝血檢測設備正在推動市場增長，它有助於監測接受抗凝治療的患者的血流量。 這些因素正在推動凝血檢測市場的需求。

COVID-19 大流行帶來了許多困難，由於許多企業在全球範圍內停業，造成了重大經濟損失。 建立了進出口限制。 COVID-19 大流行對全球凝血檢測市場產生了有益影響。 許多政府機構正在採取許多行動來幫助企業度過冠狀病毒大流行。 許多政府機構正在採取許多行動來幫助企業度過冠狀病毒大流行。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特的五力分析
  • 主要公司的定位
  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • COVID-19 影響分析
  • 價值鏈分析
  • 市場份額分析
  • 監管準則
  • 關鍵法規分析
  • 專利情況

第 4 章止血市場：按產品分類

  • 概覽
    • 市場規模和預測
  • 設備
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 消耗品
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 5 章止血市場：按應用

  • 概覽
    • 市場規模和預測
  • 凝血□原時間
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 活化部分凝血活□時間
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 凝血□時間
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 活化凝血時間
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 6 章止血市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 臨床實驗室
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 即時檢測
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 7 章止血市場：按地區

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機會
    • 北美市場規模和預測：按產品
    • 北美市場規模和預測：按應用
    • 北美市場規模和預測：按最終用戶分類
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機會
    • 歐洲市場規模和預測：按產品
    • 歐洲市場規模和預測：按應用分類
    • 歐洲市場規模和預測：按最終用戶分類
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 英國
      • 法國
      • 西班牙
      • 意大利
      • 其他歐洲地區
  • 亞太地區
    • 主要趨勢和機會
    • 亞太市場規模和預測：按產品
    • 亞太市場規模和預測：按應用
    • 亞太市場規模和預測：按最終用戶分類
    • 亞太地區的市場規模和預測：按國家/地區分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 澳大利亞
      • 其他亞太地區
  • 拉美
    • 主要趨勢和機會
    • LAMEA 市場規模和預測：按產品
    • LAMEA 市場規模和預測：按應用分類
    • LAMEA 市場規模和預測：按最終用戶分類
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 阿聯酋
      • 南非
      • LAMEA 的其餘部分

第八章公司情況

  • 介紹
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 主要發展

第九章公司簡介

  • Alere Inc.
  • Nihon Kohden Corporation
  • F. Hoffmann-La Roche Ltd.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Diagnostica Stago Sas
  • Helena Laboratories
  • Abbott Laboratories
  • Medtronic plc
  • Micropoint Biosciences
Product Code: A03148

The global coagulation testing market size is envisioned to garner $8,777.3 million by 2031, growing from $3,101.7 million in 2021 at a CAGR of 11.5% from 2022 to 2031.

Medical professionals use coagulation tests to evaluate the hemostasis system. A coagulometer, which monitors and assesses the rate of clot formation or blood coagulation, is mostly used to conduct this test. These examinations reduce the risk of heart attack, thrombosis, and embolism by detecting the presence of blood clots in blood arteries.

Hemostasis (coagulation), a complicated process that regulates blood flow and clot formation, is controlled by numerous enzymes and proteins.

The market is expanding as a result of ongoing technological developments in coagulation testing equipment. The key growth reasons for the coagulation testing market are the rising prevalence of different blood clotting disorders, including deep vein thrombosis (DVT) and haemophilia, as well as the global ageing population. The market is comprehensively evaluated in the study on the global coagulation testing market growth.

Due to stringent government regulations along with high risk and costs associated with tests and treatment which limits its usage to only the population which is economically capable gives a negative impact on the global coagulation testing markets.

In the self-testing technology, the smartphone-based blood coagulation testing device which is driving the growth of the market helps to monitors the blood flow in patients by undergoing an anticoagulant therapy. These factors drives the coagulation testing market demand.

The COVID-19 pandemic brought about a number of difficulties that resulted in significant economic losses as a result of the global shutdown of many firms. There were established import-export limitations. The COVID-19 pandemic has had a beneficial impact on the market for coagulation testing worldwide. Numerous government agencies are taking a number of actions to help businesses survive the coronavirus epidemic. Many government agencies are taking a number of actions to help businesses survive the coronavirus outbreak.

The key players profiled in this report include Thermo Fisher Scientific Inc., Helena Laboratories Corporation., Micropoint Biosciences, Medtronic, F. Hoffmann-La Roche Ltd, NIHON KOHDEN CORPORATION., Abbott., Sysmex Corporation, BD Biosciences., and Danaher.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the coagulation testing market analysis from 2021 to 2031 to identify the prevailing coagulation testing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the coagulation testing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global coagulation testing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Instruments
  • Consumables

By Application

  • Prothrombin Time
  • Activated Partial Thromboplastin Time
  • Thrombin Time
  • Activated Clotting Time

By End User

  • Hospitals
  • Clinical Laboratories
  • Point-of-Care Testing
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest Of Asia Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Alere Inc.
    • Nihon Kohden Corporation
    • F. Hoffmann-La Roche Ltd.
    • Sysmex Corporation
    • Thermo Fisher Scientific Inc.
    • Diagnostica Stago Sas
    • Helena Laboratories
    • Abbott Laboratories
    • Medtronic plc
    • Micropoint Biosciences

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Value Chain Analysis
  • 3.8.Market Share Analysis
  • 3.9.Regulatory Guidelines
  • 3.10.Key Regulation Analysis
  • 3.11.Patent Landscape

CHAPTER 4: COAGULATION TESTING MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Instruments
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Consumables
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: COAGULATION TESTING MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Prothrombin Time
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Activated Partial Thromboplastin Time
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Thrombin Time
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Activated Clotting Time
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: COAGULATION TESTING MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Clinical Laboratories
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Point-of-Care Testing
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country
  • 6.5 Others
    • 6.5.1 Key market trends, growth factors and opportunities
    • 6.5.2 Market size and forecast, by region
    • 6.5.3 Market analysis by country

CHAPTER 7: COAGULATION TESTING MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product
    • 7.2.3 North America Market size and forecast, by Application
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Product
      • 7.2.5.1.2 Market size and forecast, by Application
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Product
      • 7.2.5.2.2 Market size and forecast, by Application
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Product
      • 7.2.5.3.2 Market size and forecast, by Application
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product
    • 7.3.3 Europe Market size and forecast, by Application
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Product
      • 7.3.5.1.2 Market size and forecast, by Application
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 United Kingdom
      • 7.3.5.2.1 Market size and forecast, by Product
      • 7.3.5.2.2 Market size and forecast, by Application
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 France
      • 7.3.5.3.1 Market size and forecast, by Product
      • 7.3.5.3.2 Market size and forecast, by Application
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Spain
      • 7.3.5.4.1 Market size and forecast, by Product
      • 7.3.5.4.2 Market size and forecast, by Application
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Italy
      • 7.3.5.5.1 Market size and forecast, by Product
      • 7.3.5.5.2 Market size and forecast, by Application
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Product
      • 7.3.5.6.2 Market size and forecast, by Application
      • 7.3.5.6.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Market size and forecast, by Product
      • 7.4.5.1.2 Market size and forecast, by Application
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 Japan
      • 7.4.5.2.1 Market size and forecast, by Product
      • 7.4.5.2.2 Market size and forecast, by Application
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Product
      • 7.4.5.3.2 Market size and forecast, by Application
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 South Korea
      • 7.4.5.4.1 Market size and forecast, by Product
      • 7.4.5.4.2 Market size and forecast, by Application
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 Australia
      • 7.4.5.5.1 Market size and forecast, by Product
      • 7.4.5.5.2 Market size and forecast, by Application
      • 7.4.5.5.3 Market size and forecast, by End User
      • 7.4.5.6 Rest Of Asia Pacific
      • 7.4.5.6.1 Market size and forecast, by Product
      • 7.4.5.6.2 Market size and forecast, by Application
      • 7.4.5.6.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product
    • 7.5.3 LAMEA Market size and forecast, by Application
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Product
      • 7.5.5.1.2 Market size and forecast, by Application
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Product
      • 7.5.5.2.2 Market size and forecast, by Application
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 UAE
      • 7.5.5.3.1 Market size and forecast, by Product
      • 7.5.5.3.2 Market size and forecast, by Application
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 South Africa
      • 7.5.5.4.1 Market size and forecast, by Product
      • 7.5.5.4.2 Market size and forecast, by Application
      • 7.5.5.4.3 Market size and forecast, by End User
      • 7.5.5.5 Rest of LAMEA
      • 7.5.5.5.1 Market size and forecast, by Product
      • 7.5.5.5.2 Market size and forecast, by Application
      • 7.5.5.5.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Alere Inc.
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Nihon Kohden Corporation
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 F. Hoffmann-La Roche Ltd.
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Sysmex Corporation
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Thermo Fisher Scientific Inc.
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Diagnostica Stago Sas
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Helena Laboratories
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Abbott Laboratories
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Medtronic plc
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Micropoint Biosciences
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 2. COAGULATION TESTING MARKET SIZE, FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. COAGULATION TESTING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. COAGULATION TESTING MARKET SIZE, FOR CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. COAGULATION TESTING MARKET FOR CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. GLOBAL COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 7. COAGULATION TESTING MARKET SIZE, FOR PROTHROMBIN TIME, BY REGION, 2021-2031 ($MILLION)
  • TABLE 8. COAGULATION TESTING MARKET FOR PROTHROMBIN TIME, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 9. COAGULATION TESTING MARKET SIZE, FOR ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. COAGULATION TESTING MARKET FOR ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 11. COAGULATION TESTING MARKET SIZE, FOR THROMBIN TIME, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. COAGULATION TESTING MARKET FOR THROMBIN TIME, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 13. COAGULATION TESTING MARKET SIZE, FOR ACTIVATED CLOTTING TIME, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. COAGULATION TESTING MARKET FOR ACTIVATED CLOTTING TIME, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. GLOBAL COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 16. COAGULATION TESTING MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. COAGULATION TESTING MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 18. COAGULATION TESTING MARKET SIZE, FOR CLINICAL LABORATORIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 19. COAGULATION TESTING MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 20. COAGULATION TESTING MARKET SIZE, FOR POINT-OF-CARE TESTING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. COAGULATION TESTING MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. COAGULATION TESTING MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 23. COAGULATION TESTING MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 24. COAGULATION TESTING MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 25. NORTH AMERICA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 26. NORTH AMERICA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 27. NORTH AMERICA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 28. NORTH AMERICA COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 29. U.S. COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 30. U.S. COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 31. U.S. COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 32. CANADA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 33. CANADA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 34. CANADA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 35. MEXICO COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 36. MEXICO COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 37. MEXICO COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 38. EUROPE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 39. EUROPE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 40. EUROPE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 41. EUROPE COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 42. GERMANY COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 43. GERMANY COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 44. GERMANY COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 45. UNITED KINGDOM COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 46. UNITED KINGDOM COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. UNITED KINGDOM COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 48. FRANCE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 49. FRANCE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 50. FRANCE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 51. SPAIN COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 52. SPAIN COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 53. SPAIN COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 54. ITALY COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 55. ITALY COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 56. ITALY COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 57. REST OF EUROPE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 58. REST OF EUROPE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 59. REST OF EUROPE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 60. ASIA-PACIFIC COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 61. ASIA-PACIFIC COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 62. ASIA-PACIFIC COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 63. ASIA-PACIFIC COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 64. CHINA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 65. CHINA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 66. CHINA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 67. JAPAN COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 68. JAPAN COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 69. JAPAN COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 70. INDIA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 71. INDIA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 72. INDIA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 73. SOUTH KOREA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 74. SOUTH KOREA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 75. SOUTH KOREA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 76. AUSTRALIA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 77. AUSTRALIA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 78. AUSTRALIA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 79. REST OF ASIA PACIFIC COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 81. REST OF ASIA PACIFIC COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 82. LAMEA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 83. LAMEA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 84. LAMEA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 85. LAMEA COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 86. BRAZIL COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 87. BRAZIL COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 88. BRAZIL COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 89. SAUDI ARABIA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 90. SAUDI ARABIA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 91. SAUDI ARABIA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 92. UAE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 93. UAE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 94. UAE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 95. SOUTH AFRICA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 96. SOUTH AFRICA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 97. SOUTH AFRICA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 98. REST OF LAMEA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 99. REST OF LAMEA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 100. REST OF LAMEA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 101.ALERE INC.: COMPANY SNAPSHOT
  • TABLE 102.ALERE INC.: OPERATING SEGMENTS
  • TABLE 103.ALERE INC.: PRODUCT PORTFOLIO
  • TABLE 104.ALERE INC.: NET SALES,
  • TABLE 105.ALERE INC.: KEY STRATERGIES
  • TABLE 106.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
  • TABLE 107.NIHON KOHDEN CORPORATION: OPERATING SEGMENTS
  • TABLE 108.NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO
  • TABLE 109.NIHON KOHDEN CORPORATION: NET SALES,
  • TABLE 110.NIHON KOHDEN CORPORATION: KEY STRATERGIES
  • TABLE 111.F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 112.F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
  • TABLE 113.F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
  • TABLE 114.F. HOFFMANN-LA ROCHE LTD.: NET SALES,
  • TABLE 115.F. HOFFMANN-LA ROCHE LTD.: KEY STRATERGIES
  • TABLE 116.SYSMEX CORPORATION: COMPANY SNAPSHOT
  • TABLE 117.SYSMEX CORPORATION: OPERATING SEGMENTS
  • TABLE 118.SYSMEX CORPORATION: PRODUCT PORTFOLIO
  • TABLE 119.SYSMEX CORPORATION: NET SALES,
  • TABLE 120.SYSMEX CORPORATION: KEY STRATERGIES
  • TABLE 121.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 122.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 123.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 124.THERMO FISHER SCIENTIFIC INC.: NET SALES,
  • TABLE 125.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
  • TABLE 126.DIAGNOSTICA STAGO SAS: COMPANY SNAPSHOT
  • TABLE 127.DIAGNOSTICA STAGO SAS: OPERATING SEGMENTS
  • TABLE 128.DIAGNOSTICA STAGO SAS: PRODUCT PORTFOLIO
  • TABLE 129.DIAGNOSTICA STAGO SAS: NET SALES,
  • TABLE 130.DIAGNOSTICA STAGO SAS: KEY STRATERGIES
  • TABLE 131.HELENA LABORATORIES: COMPANY SNAPSHOT
  • TABLE 132.HELENA LABORATORIES: OPERATING SEGMENTS
  • TABLE 133.HELENA LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 134.HELENA LABORATORIES: NET SALES,
  • TABLE 135.HELENA LABORATORIES: KEY STRATERGIES
  • TABLE 136.ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 137.ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 138.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 139.ABBOTT LABORATORIES: NET SALES,
  • TABLE 140.ABBOTT LABORATORIES: KEY STRATERGIES
  • TABLE 141.MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 142.MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 143.MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 144.MEDTRONIC PLC: NET SALES,
  • TABLE 145.MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 146.MICROPOINT BIOSCIENCES: COMPANY SNAPSHOT
  • TABLE 147.MICROPOINT BIOSCIENCES: OPERATING SEGMENTS
  • TABLE 148.MICROPOINT BIOSCIENCES: PRODUCT PORTFOLIO
  • TABLE 149.MICROPOINT BIOSCIENCES: NET SALES,
  • TABLE 150.MICROPOINT BIOSCIENCES: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.COAGULATION TESTING MARKET SEGMENTATION
  • FIGURE 2.COAGULATION TESTING MARKET,2021-2031
  • FIGURE 3.COAGULATION TESTING MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.COAGULATION TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.VALUE CHAIN ANALYSIS
  • FIGURE 13.MARKET SHARE ANALYSIS
  • FIGURE 14.REGULATORY GUIDELINES
  • FIGURE 15.KEY REGULATION ANALYSIS
  • FIGURE 16.PATENT ANALYSIS BY COMPANY
  • FIGURE 17.PATENT ANALYSIS BY COUNTRY
  • FIGURE 18.COAGULATION TESTING MARKET,BY PRODUCT,2021(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS COAGULATION TESTING MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES COAGULATION TESTING MARKET,2021-2031(%)
  • FIGURE 21.COAGULATION TESTING MARKET,BY APPLICATION,2021(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PROTHROMBIN TIME COAGULATION TESTING MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF ACTIVATED PARTIAL THROMBOPLASTIN TIME COAGULATION TESTING MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF THROMBIN TIME COAGULATION TESTING MARKET,2021-2031(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF ACTIVATED CLOTTING TIME COAGULATION TESTING MARKET,2021-2031(%)
  • FIGURE 26.COAGULATION TESTING MARKET,BY END USER,2021(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF HOSPITALS COAGULATION TESTING MARKET,2021-2031(%)
  • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF CLINICAL LABORATORIES COAGULATION TESTING MARKET,2021-2031(%)
  • FIGURE 29.COMPARATIVE SHARE ANALYSIS OF POINT-OF-CARE TESTING COAGULATION TESTING MARKET,2021-2031(%)
  • FIGURE 30.COMPARATIVE SHARE ANALYSIS OF OTHERS COAGULATION TESTING MARKET,2021-2031(%)
  • FIGURE 31.COAGULATION TESTING MARKET BY REGION,2021
  • FIGURE 32.U.S. COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 33.CANADA COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 34.MEXICO COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 35.GERMANY COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 36.UNITED KINGDOM COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 37.FRANCE COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 38.SPAIN COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 39.ITALY COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 40.REST OF EUROPE COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 41.CHINA COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 42.JAPAN COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 43.INDIA COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 44.SOUTH KOREA COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 45.AUSTRALIA COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 46.REST OF ASIA PACIFIC COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 47.BRAZIL COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 48.SAUDI ARABIA COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 49.UAE COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 50.SOUTH AFRICA COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 51.REST OF LAMEA COAGULATION TESTING MARKET,2021-2031($MILLION)
  • FIGURE 52. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 53. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 54. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 55.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 56.COMPETITIVE DASHBOARD
  • FIGURE 57.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 58.ALERE INC..: NET SALES ,($MILLION)
  • FIGURE 59.NIHON KOHDEN CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 60.F. HOFFMANN-LA ROCHE LTD..: NET SALES ,($MILLION)
  • FIGURE 61.SYSMEX CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 62.THERMO FISHER SCIENTIFIC INC..: NET SALES ,($MILLION)
  • FIGURE 63.DIAGNOSTICA STAGO SAS.: NET SALES ,($MILLION)
  • FIGURE 64.HELENA LABORATORIES.: NET SALES ,($MILLION)
  • FIGURE 65.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
  • FIGURE 66.MEDTRONIC PLC.: NET SALES ,($MILLION)
  • FIGURE 67.MICROPOINT BIOSCIENCES.: NET SALES ,($MILLION)